Acumen Pharmaceuticals ABOS Cash Flow Statement (2020-2026)

NASDAQ ABOS
$3.19 +0.04 (+1.27%)
At close: Aug 20, 2026 · 4:00 PM EDT
Cash Flow Statement Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income (Quarter)
-3.92M-8.39M-9.24M-22.91M-51.19M-14.13M-13.18M-11.63M-12.91M-14.70M-14.77M-21.57M-29.79M-38.42M-28.92M-40.78M-25.94M-24.61M-21.15M-32.54M
Depreciation and Depletion (Quarter)
0.00M0.00M0.01M0.01M0.01M0.01M0.01M0.01M0.02M0.02M0.02M0.02M0.01M0.01M0.02M0.01M0.01M0.01M0.01M
Share-based Compensation (Quarter)
0.30M-0.56M0.62M-0.39M2.83M2.91M-2.91M6.14M2.48M-2.45M7.26M2.34M0.07M4.90M-4.90M2.40M2.52M
Asset Writedowns and Impairment (Quarter)
0.00M
Cash from Operations (Quarter)
-7.69M-3.64M-8.30M-6.47M-9.18M-11.20M-10.18M-11.67M-12.90M-8.31M-17.86M-16.55M-24.60M-27.21M-34.12M-31.83M-30.49M-19.10M-24.13M-18.07M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
-0.16M-0.22M-0.17M-0.19M0.09M0.33M0.30M0.71M1.78M1.76M1.46M1.38M0.42M0.59M0.06M0.28M-0.11M-0.03M0.19M
Amortization of Deferred Charges (Quarter)
0.03M0.03M0.03M0.04M0.04M0.04M0.03M0.02M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M
Depreciation & Amortization (CF) (Quarter)
0.00M0.00M0.01M0.01M0.01M0.01M0.01M0.01M0.02M0.02M0.02M0.02M0.01M0.01M0.02M0.01M0.01M0.01M0.01M
Change in Working Capital
Change in Account Payables (Quarter)
-0.89M0.71M0.12M0.46M0.42M-0.44M-0.88M1.26M-0.66M0.02M1.70M1.12M-1.86M3.31M-4.59M1.05M-1.42M-0.13M1.05M11.78M
Change in Accured Expenses (Quarter)
-0.01M2.80M-1.76M0.33M0.37M0.50M-0.60M-0.41M0.83M3.06M-3.53M1.15M0.89M1.52M0.06M4.90M-3.90M2.23M-5.04M2.50M
Other Working Capital Changes (Quarter)
-0.03M-0.03M-0.03M-0.04M-0.04M-0.04M-0.03M-0.01M-0.02M-0.03M-0.03M
Investing Activities
Capital Expenditures (Quarter)
0.01M0.03M0.01M0.03M0.08M0.04M0.01M0.01M0.01M0.01M0.08M0.01M
Change in Acquisitions & Divestments (Quarter)
4.00M11.86M56.00M9.00M10.20M11.06M34.73M22.98M36.10M49.51M88.41M44.76M63.82M41.50M40.51M26.25M27.02M26.00M
Cash from Investing Activities (Quarter)
-94.10M-10.01M-5.10M8.79M55.92M-20.42M-41.93M11.06M-92.00M-48.81M-9.20M37.70M-10.13M29.66M28.69M38.48M40.51M26.25M-13.81M26.00M
Financing Activities
Other financing activities (Quarter)
-1.25M0.61M0.00M-0.02M0.33M0.15M0.04M0.00M0.14M-0.30M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
138.53M-0.00M3.79M122.29M-0.39M7.94M
Misc.
Cash from Financing Activities (Quarter)
168.78M0.01M-0.26M4.18M-0.14M122.76M29.13M7.11M-0.13M-0.04M-0.01M-0.04M0.00M35.74M-0.28M
Change in Cash (Quarter)
66.99M-13.64M-13.40M2.30M46.47M-27.44M-52.10M-0.75M17.86M-27.99M-19.95M21.03M-34.77M2.44M-5.47M6.65M10.02M7.16M-2.19M7.65M
Free Cash Flow (Quarter)
-7.70M-3.67M-8.31M-6.50M-9.27M-11.24M-10.18M-11.67M-12.91M-8.33M-17.87M-16.55M-24.60M-27.21M-34.20M-31.84M-30.49M-19.10M-24.13M-18.07M
Net Cash Flow (Quarter)
66.99M-13.64M-13.40M2.32M46.47M-27.44M-52.10M-0.75M17.86M-27.99M-19.95M21.03M-34.77M2.44M-5.47M6.65M10.02M7.16M-2.19M7.65M